Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos
- PMID: 17493584
- DOI: 10.1016/j.bbrc.2007.04.172
Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos
Abstract
This work represents the first guide for using steric-block antisense oligos as tools for effective and targeted modification of RNA splicing. Comparison of several steric-block oligo types shows the properties of Morpholinos provide significant advantages over other potential splice-blocking oligos. The procedures and complications of designing effective splice-blocking Morpholino oligos are described. The design process requires complete pre-mRNA sequence for defining suitable targets, which usually generate specific predictable messengers. To validate the targeting procedure, the level and nature of transcript alteration is characterized by RT-PCR analysis of splice modification in a beta-globin splice model system. An oligo-walking study reveals that while U1 and U2 small nuclear RiboNucleoProtein (snRNP) binding sites are the most effective targets for blocking splicing, inclusion of these sites is not required to achieve effective splice modifications. The most effective targeting strategy employs simultaneously blocking snRNP binding sites and splice-junctions. The work presented here continues to be the basis for most of the successful Morpholino oligos designed for the worldwide research community to block RNA splicing.
Similar articles
-
Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors.Med Hypotheses. 2005;65(5):905-7. doi: 10.1016/j.mehy.2004.12.032. Med Hypotheses. 2005. PMID: 16023790
-
Regulation of pre-mRNA splicing by antisense oligonucleotides.Curr Opin Drug Discov Devel. 1999 Mar;2(2):147-51. Curr Opin Drug Discov Devel. 1999. PMID: 19649941
-
L30 binds the nascent RPL30 transcript to repress U2 snRNP recruitment.Mol Cell. 2008 Jun 20;30(6):732-42. doi: 10.1016/j.molcel.2008.05.002. Mol Cell. 2008. PMID: 18570876
-
Making antisense of splicing.Curr Opin Mol Ther. 2005 Oct;7(5):476-82. Curr Opin Mol Ther. 2005. PMID: 16248283 Review.
-
Can donor splice site recognition occur without the involvement of U1 snRNP?Biochem Soc Trans. 2008 Jun;36(Pt 3):548-50. doi: 10.1042/BST0360548. Biochem Soc Trans. 2008. PMID: 18482005 Review.
Cited by
-
Protocadherin-17 function in Zebrafish retinal development.Dev Neurobiol. 2013 Apr;73(4):259-73. doi: 10.1002/dneu.22053. Epub 2013 Jan 24. Dev Neurobiol. 2013. PMID: 22927092 Free PMC article.
-
Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype.Hum Mol Genet. 2010 Nov 15;19(22):4409-20. doi: 10.1093/hmg/ddq364. Epub 2010 Sep 6. Hum Mol Genet. 2010. PMID: 20819949 Free PMC article.
-
RNA-Based Strategies for Cancer Therapy: In Silico Design and Evaluation of ASOs for Targeted Exon Skipping.Int J Mol Sci. 2023 Oct 3;24(19):14862. doi: 10.3390/ijms241914862. Int J Mol Sci. 2023. PMID: 37834310 Free PMC article.
-
Mutant Ahi1 Affects Retinal Axon Projection in Zebrafish via Toxic Gain of Function.Front Cell Neurosci. 2019 Mar 21;13:81. doi: 10.3389/fncel.2019.00081. eCollection 2019. Front Cell Neurosci. 2019. PMID: 30949029 Free PMC article.
-
Selective down-regulation of nuclear poly(ADP-ribose) glycohydrolase.PLoS One. 2009;4(3):e4896. doi: 10.1371/journal.pone.0004896. Epub 2009 Mar 25. PLoS One. 2009. PMID: 19319190 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources